Real-world research will support research and development of children's medicines, and the industry is taking a new step forward.
Under the outbreak of China's medicine semi-annual report: revenue only medical device growth Murray net profit super Hengrui.
New migraine medicine! Lingbei CGRP targeted antibody Vyepti during migraine attack preventive treatment PHASE III study was successful!
The development of traditional Chinese medicine in modern scientific and technological innovation urgently needs strong support from national policies.
Notice of public consultation on the Technical Guidelines for the Study of the Quality of New Chinese Medicines.
Clinical CRO Fang en medicine changed its name to Kun Yu.
New oral medicine for multiple sclerosis! Next-generation immunomodulant IMU-838: Rapid suppression of MRI lesions, significant efficacy, high safety!
Ministry of Education: We will set up additional courses on Chinese medicine epidemic diseases
New medicine for rare diseases! Ryplazim (C-PLGD) re-applys for market: the first congenital clysolytic deficiency (C-PLGD) treatment!
million yuan B round of financing of the collection of medicine Kang in the end what charm?
Vertex "old medicine" for the prevention and treatment of Alzheimer's disease has obtained positive animal test results.
Kun Pharmaceutical Group ranks among the top 100 Chinese medicine enterprises TOP17.
Can you still eat "bubble medicine" bananas?
The lowest unit price of Chinese medicine collection entered the era of 1 cent.
East China Medicine Acapo sugar tablets have been approved by the U.S. FDA.
Genome Medicine: Reveals the important role of non-coded RNA in the progression of non-small cell lung cancer and tumor immunity.
EClinical Medicine: Increased risk of inflammatory macular degeneration in patients with bone marrow-boosting tumors.
Fill the void! Technical guidelines for the quality research of new Chinese medicines have been attacked.
China County Health Conference: Wu Yiling academician team of Chinese medicine research
And platinum medicine at the 16th Protein Engineering Summit (PEGS) showcased innovative CCR8 antibodies.